FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases ...Middle East

PR Newswire - News
FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases
SILVER SPRING, Md., Oct. 31, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases. Wezlana, like Stelara, is approved to treat the...

Hence then, the article about fda approves interchangeable biosimilar for multiple inflammatory diseases was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News